• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Molecular profiling of primary renal diffuse large B-cell lymphoma unravels a proclivity for immune-privileged tropism.

作者信息

Künstner Axel, von Kopylow Vera, Lohneis Philipp, Kümmel Matthias, Witte Hanno M, Bastian Lorenz, Bernard Veronica, Stölting Stephanie, Kusch Kathrin, von Bubnoff Nikolas, Steinestel Konrad, Arndt Annette, Merz Hartmut, Busch Hauke, Feller Alfred C, Gebauer Niklas

机构信息

University Cancer Center Schleswig-Holstein, University Hospital of Schleswig-Holstein, Lübeck, Germany.

Medical Systems Biology Group, Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.

出版信息

Blood Adv. 2025 Aug 12;9(15):3900-3904. doi: 10.1182/bloodadvances.2025016002.

DOI:10.1182/bloodadvances.2025016002
PMID:40402672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12332925/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/169a/12332925/2e4f603edf2a/BLOODA_ADV-2025-016002-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/169a/12332925/d44ad3aa135f/BLOODA_ADV-2025-016002-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/169a/12332925/2e4f603edf2a/BLOODA_ADV-2025-016002-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/169a/12332925/d44ad3aa135f/BLOODA_ADV-2025-016002-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/169a/12332925/2e4f603edf2a/BLOODA_ADV-2025-016002-gr2.jpg

相似文献

1
Molecular profiling of primary renal diffuse large B-cell lymphoma unravels a proclivity for immune-privileged tropism.原发性肾弥漫性大B细胞淋巴瘤的分子谱分析揭示了其对免疫豁免趋向性的偏好。
Blood Adv. 2025 Aug 12;9(15):3900-3904. doi: 10.1182/bloodadvances.2025016002.
2
Primary large B-cell lymphomas of immune-privileged sites.免疫豁免部位的原发性大B细胞淋巴瘤
Blood. 2024 Dec 19;144(25):2593-2603. doi: 10.1182/blood.2023020911.
3
A Novel Prognostic Score for Disease Progression and Mortality in Patients With Newly Diagnosed Primary Large B-Cell Lymphoma of Immune-Privileged Sites.一种用于新诊断的免疫豁免部位原发性大B细胞淋巴瘤患者疾病进展和死亡率的新型预后评分
Hematol Oncol. 2025 Jul;43(4):e70115. doi: 10.1002/hon.70115.
4
Comparative analysis of the tumor microenvironment in primary CNS and testicular large B-cell lymphomas using digital image analysis and its implications for immunotherapy.使用数字图像分析对原发性中枢神经系统和睾丸大B细胞淋巴瘤的肿瘤微环境进行比较分析及其对免疫治疗的意义。
Hum Pathol. 2025 Sep;163:105874. doi: 10.1016/j.humpath.2025.105874. Epub 2025 Jul 24.
5
Decoding the immune microenvironment of secondary chronic myelomonocytic leukemia due to diffuse large B-cell lymphoma with CD19 CAR-T failure by single-cell RNA-sequencing.通过单细胞RNA测序解析弥漫性大B细胞淋巴瘤伴CD19嵌合抗原受体T细胞（CAR-T）治疗失败所致继发性慢性粒单核细胞白血病的免疫微环境
Chin Med J (Engl). 2025 Aug 5;138(15):1866-1881. doi: 10.1097/CM9.0000000000003690. Epub 2025 Jul 7.
6
Sodium 2-Mercaptoethanesulfonate (MESNA), Ifosfamide, Mitoxantrone, and Etoposide (MINE) in Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is the Old Regimen Still Gold?2-巯基乙烷磺酸钠（美司钠）、异环磷酰胺、米托蒽醌和依托泊苷（MINE方案）用于不符合移植条件的复发/难治性弥漫性大B细胞淋巴瘤：旧方案是否仍为最佳方案？
Cureus. 2025 Jul 1;17(7):e87128. doi: 10.7759/cureus.87128. eCollection 2025 Jul.
7
High expression of RHOF is an effective diagnostic marker and a potential prognostic indicator for primary mediastinal large B-cell lymphoma.RHOF的高表达是原发性纵隔大B细胞淋巴瘤的有效诊断标志物和潜在的预后指标。
Virchows Arch. 2024 Dec 4. doi: 10.1007/s00428-024-03993-4.
8
Immune Checkpoint Molecule Expression, 9p24.1 Gene Alterations, and Tumor Microenvironment of Primary Central Nervous System Lymphomas and Their Clinical Relevance.原发性中枢神经系统淋巴瘤的免疫检查点分子表达、9p24.1基因改变及肿瘤微环境及其临床相关性
Appl Immunohistochem Mol Morphol. 2025 Jun 30. doi: 10.1097/PAI.0000000000001273.
9
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study.R-GemOx治疗复发或难治性弥漫性大B细胞淋巴瘤的疗效：一项多中心队列研究。
Am J Hematol. 2025 Apr;100(4):606-615. doi: 10.1002/ajh.27630. Epub 2025 Feb 7.
10
CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study.CD22 导向的 CAR T 细胞疗法治疗 CD19 导向的 CAR T 细胞疗法后进展的大 B 细胞淋巴瘤：一项剂量探索性 1 期研究。
Lancet. 2024 Jul 27;404(10450):353-363. doi: 10.1016/S0140-6736(24)00746-3. Epub 2024 Jul 9.

引用本文的文献

1
Molecular profiling of primary renal marginal zone lymphoma reveals overlapping features with extranodal marginal zone lymphoma.原发性肾边缘区淋巴瘤的分子谱分析揭示了与结外边缘区淋巴瘤重叠的特征。
Blood Adv. 2025 Jul 22;9(14):3658-3663. doi: 10.1182/bloodadvances.2025016263.

本文引用的文献

1
Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL.睾丸大B细胞淋巴瘤在基因上与原发性中枢神经系统淋巴瘤相似，且与淋巴结弥漫性大B细胞淋巴瘤不同。
Hemasphere. 2024 Oct 7;8(10):e70024. doi: 10.1002/hem3.70024. eCollection 2024 Oct.
2
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation.弥漫性大B细胞淋巴瘤的转录组分类鉴定出一个具有可靶向的MYC失调的高危活化B细胞样亚群。
Nat Commun. 2024 Aug 8;15(1):6790. doi: 10.1038/s41467-024-50830-y.
3
Primary large B-cell lymphomas of immune-privileged sites.
免疫豁免部位的原发性大B细胞淋巴瘤
Blood. 2024 Dec 19;144(25):2593-2603. doi: 10.1182/blood.2023020911.
4
Molecular and clinical diversity in primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤的分子和临床多样性。
Ann Oncol. 2023 Feb;34(2):186-199. doi: 10.1016/j.annonc.2022.11.002. Epub 2022 Nov 17.
5
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.《世界卫生组织造血与淋巴组织肿瘤分类》第五版：淋巴肿瘤。
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
6
The genomic and transcriptional landscape of primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤的基因组和转录组图谱。
Nat Commun. 2022 May 10;13(1):2558. doi: 10.1038/s41467-022-30050-y.
7
High Detection Rate of Mutations in Cerebrospinal Fluid From Patients With CNS Lymphomas.中枢神经系统淋巴瘤患者脑脊液中突变的高检出率
JCO Precis Oncol. 2019 Dec;3:1-13. doi: 10.1200/PO.18.00308.
8
Whole-Exome Sequencing Reveals New Potential Mutations Genes for Primary Mucosa-Associated Lymphoid Tissue Lymphoma Arising From the Kidney.全外显子测序揭示了肾原发性黏膜相关淋巴组织淋巴瘤新的潜在突变基因。
Front Oncol. 2021 Jan 8;10:609839. doi: 10.3389/fonc.2020.609839. eCollection 2020.
9
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.具有治疗意义的弥漫性大 B 细胞淋巴瘤遗传亚型的概率分类工具。
Cancer Cell. 2020 Apr 13;37(4):551-568.e14. doi: 10.1016/j.ccell.2020.03.015.
10
Primary renal lymphoma: A population-based analysis using the SEER program (1973-2015).原发性肾淋巴瘤：利用 SEER 计划进行的基于人群的分析（1973-2015）。
Eur J Haematol. 2020 May;104(5):390-399. doi: 10.1111/ejh.13360. Epub 2020 Mar 3.